Showing results (251-260 of 6,284) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|January 28, 2026
Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysisSama M Abdel-Rahman, Rama Al-Shiab, Ermeena Shah, et al.
Diabetes, Obesity & Metabolism|January 29, 2026
Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected dataFrank M Gao, Kartik Kishore, Dinesh Pandey, et al.
Diabetes, Obesity & Metabolism|February 3, 2026
Association of four insulin resistance indices with liver-related adverse outcomes: A prospective cohort studyXiao-Meng Wang, Hao Yan, Wen-Fang Zhong, et al.
Diabetes, Obesity & Metabolism|January 23, 2026
Lorcaserin induces abdominal fat loss with associated improvements of the circulating metabolome/lipidome and no changes in the myostatin-activin-follistatin-IGF-1 axes: A 6-month long randomized placebo-controlled clinical trialArantxa Ramirez-Cisneros, Valeria Gutierrez de Piñeres, Claudia S Tamayo-Torres, et al.
Diabetes, Obesity & Metabolism|January 21, 2026
Oral indole-3-propionic acid preserves β-cell function and improves glucose homeostasis in diabetic mice via FOXA1-SGPP1-HSPA5 signallingXin Liu, Zixiao Liang, Chunxun Liu, et al.
Diabetes, Obesity & Metabolism|January 19, 2026
Efficacy of once-weekly insulin efsitora versus once-daily basal insulin in type 2 diabetes: A systematic review and meta-analysisMariam Akmal, Sheharyar Tariq, Mohsan Mustafa, et al.
Diabetes, Obesity & Metabolism|January 20, 2026
Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo-Neo T2DM studyStefan Pscherer, Andreas Fritsche, Helmut Anderten, et al.
Diabetes, Obesity & Metabolism|January 21, 2026
Lipoprotein(a) is associated with ASCVD in individuals with non-diabetes, prediabetes, or diabetes independent of CRPZenglei Zhang, Lin Zhao, Zeyu Wang, et al.
Diabetes, Obesity & Metabolism|March 26, 2025
Type 1 diabetes risk factors, risk prediction and presymptomatic detection: Evidence and guidance for screeningEzio Bonifacio, Anette-Gabriele Ziegler
Diabetes, Obesity & Metabolism|March 20, 2025
Impact of weight loss on obesity-related complications and direct healthcare costs in Japan: A modelling studyAtaru Igarashi, Silvia Capucci, Riku Ota, et al.
Pageof 629